immunotherapy
209 projects
FP6Individual fellowship2006–2010France
IMMUNADAPT · Role of the Nck adaptor proteins in adaptive immune responses
FP6Individual fellowship2006–2008Spain
PORCINE CD200 · Study of the CD200/CD200R pathway in the pig-to-human setting to elucidate the molecular bases of xenograft rejection and develop approaches that promote xenograft survival.
FP6Excellence award2005–2009Finland
CD-GENETICS · Genetic susceptibility to coeliac disease
FP6Individual fellowship2005–2007United Kingdom
CLECT-X · Functional characterization of a novel C-type lectin receptor differentially expressed in CD8alpha+ dendritic cells
FP6Individual fellowship2005–2006Germany
ATTACC · Dendritic cell-based cancer immunotherapy targeting the tumour stroma
2 partners · 2 countries
FP6Reintegration grant2005–2007Poland
GENESIS OF FEVER · Homeostasis during fever and inflammation: A Role of Epoxygenase
FP6Reintegration grant2005–2007Spain
IDDM · Development of a novel DNA vaccine and identification of an autoantigen relevant to type I diabetes
FP6Individual fellowship2005–2007France
EPISPREAD_XP · Cellular And Molecular Mechanisms Of Cross-Presentation In Epitope Spreading Following Immune Responses To Anti-Tumor Vaccines
FP6Individual fellowship2005–2007United Kingdom
TREATPLAN-TRT · A treatment planning model for targeted radionuclide therapy
FP6Doctoral network2004–2008Netherlands
DRUGS FOR THERAPY · High throughput development of drugs for immunotherapy of autoimmune diseases
12 partners · 8 countries
FP6Individual fellowship2004–2006United Kingdom
GAMMA_DELTA_IMMUNO · Gamma delta cells and immunosurveillance
FP6Individual fellowship2004–2006Italy
ELEUTHESYNTHESIS · Synthesis of Eleutheside Analogues : Potential Microtubule-Stabilizing Anticancer Drugs
FP5Training site2002–2006Netherlands
Specific immune defense of humans and animals
FP5Individual fellowship2000–2001Italy
TSWV · Immunotherapy for plant protection against tomato spotted wilt virus (TSWV)
FP4Individual fellowship1999–2001Germany
Naturally processed peptides derived from the human acetylcholine receptor. Clues for myasthenia gravis immunotherapy.
FP4Individual fellowship1997–2000Belgium
Identification of a tumor antigen recognized by autologous cytotoxic t lymphocytes on a human renal cell carcinoma
2 partners · 2 countries
FP4Individual fellowship1997–1999United Kingdom
Gene therapy of rheumatoid arthritis by means of cytokine modulation
2 partners · 2 countries
